Pantoprazole Sodium
Product Images NDC 58517-420

2 FDA label images from New Horizon Rx Group, Llc · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Pantoprazole Sodium (NDC 58517-420). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by New Horizon Rx Group, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

3488e3d7-figure-01 (3488e3d7 Figure 01)

3488e3d7-figure-01 (3488e3d7 Figure 01)
Chemical structure diagram of pantoprazole sodium sesquihydrate showing molecular connectivity and functional groups, including sodium ion and water of hydration (1.5 H2O).*
FDA Label Image

3488e3d7-figure-02 (3488e3d7 Figure 02)

3488e3d7-figure-02 (3488e3d7 Figure 02)
Label for PANTOPRAZOLE SODIUM Delayed-Release Tablets, USP, 40 mg strength, containing 30 tablets. The label shows the product NDC as 58517-420-30 and indicates it is Rx only. The labeler is New Horizon Rx Group, LLC. Storage instructions and a barcode are also visible.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.